Global women's health devices market

Global Women's Health Devices Market Size, Share, Growth Analysis, By Application(General Health & Wellness, Cancers & Other Chronic Diseases), By End-User(Hospitals & Clinics, Home Healthcare) - Industry Forecast 2024-2031


Report ID: SQSG35A2019 | Region: Global | Published Date: April, 2024
Pages: 165 | Tables: 66 | Figures: 75

Global Women's Health Devices Market Competitive Landscape

Regarding the women's health devices market's competitive environment, there are numerous businesses of varying sizes present, each with a varied product portfolio and a broad range of potential applications. F. Hoffmann-La Roche Ltd. currently holds a dominant position in the market, mostly as a result of the company's diagnostics portfolio, which includes several products that address female health issues. Numerous female cancers, as well as pregnancy and fertility, are some of the application areas of women's health that F. Hoffmann-La Roche Ltd. handles. Boston Scientific Corporation is another significant competitor with a big array of medical devices for pelvic health.

Due to their product offerings focused on female urinary incontinence and diagnostics, other businesses like Coloplast A/S and Hologic Inc. also hold a significant market share of the global market. Several rising businesses are anticipated to emerge as a result of increased investment activities in the women's health devices market, and these businesses may grow their market shares during the forecast period.

Top Players in the Global Women’s Health Devices Market

  • CooperSurgical Inc.
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Siemens AG
  • Medtronic plc
  • Boston Scientific Corporation
  • Hologic Inc.
  • Johnson & Johnson
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Thermo Fisher Scientific Inc.
  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • Danaher Corporation
  • Smith & Nephew plc

Women's Health Devices Market Recent Development

  • February 2021 – CooperSurgical announced the acquisition of U.S.-based AEGEA Medical and its FDA-approved Mara Water Vapor Ablation System, which is an endometrial ablation treatment.
  • January 2021 – Reckitt Benckiser Group PLC announced the acquisition of Queen V, a female sexual wellness brand established in the US, focused on vaginal health.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Women's Health Devices Market size was valued at USD 38.43 billion in 2019 and is poised to grow from USD 40.29 billion in 2023 to USD 468.18 billion by 2031, growing at a CAGR of 4.8% in the forecast period (2024-2031).

Regarding the women's health devices market's competitive environment, there are numerous businesses of varying sizes present, each with a varied product portfolio and a broad range of potential applications. F. Hoffmann-La Roche Ltd. currently holds a dominant position in the market, mostly as a result of the company's diagnostics portfolio, which includes several products that address female health issues. Numerous female cancers, as well as pregnancy and fertility, are some of the application areas of women's health that F. Hoffmann-La Roche Ltd. handles. Boston Scientific Corporation is another significant competitor with a big array of medical devices for pelvic health. 'CooperSurgical Inc.', 'GE Healthcare', 'Koninklijke Philips N.V.', 'Siemens AG', 'Medtronic plc', 'Boston Scientific Corporation', 'Hologic Inc.', 'Johnson & Johnson', 'Abbott Laboratories', 'F. Hoffmann-La Roche AG', 'Merck & Co., Inc.', 'Pfizer Inc.', 'Bayer AG', 'Becton, Dickinson and Company', 'Cardinal Health, Inc.', 'Thermo Fisher Scientific Inc.', 'Olympus Corporation', 'Fujifilm Holdings Corporation', 'Danaher Corporation', 'Smith & Nephew plc'

Due to the significant increase in the number of female patients over the past several years, there has been a significant rise in the need for medical equipment for the diagnosis and treatment of diseases affecting women's health, such as a variety of female cancers. Numerous studies have shown that during the past few decades, there has been a marked rise in the prevalence of disorders affecting women's health. Several governments have launched projects to increase knowledge of female ailments to lower the mortality rate among female patients with serious illnesses.

Numerous investment initiatives are being made, which is one of the most common trends in the women's health devices market and is expected to significantly boost market growth throughout the projected period. There are a lot of benefits of aggressive investment programs. Several of the benefits of these initiatives increase the number of more practical and cheap solutions available, which encourages the widespread use of these medical devices. Additionally, these investment opportunities are anticipated to lead to the introduction of cutting-edge products.

North America dominated the global women's health devices market, with a market value of US$ 15.40 billion in 2021 and is likely to continue to do so during the forecast period. A few of the factors that contribute to this region's dominance include the substantial healthcare spending on women's health in the area and the comparably larger demand for technologically advanced devices.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global women's health devices market

Product ID: SQSG35A2019

$5,300
BUY NOW GET FREE SAMPLE